Phocas Financial Corp’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$74.3K 230
2022
Q4
$74.3K Buy
+1,500
New +$61.3K 0.01% 222
2019
Q3
Sell
-1,500
Closed -$177K 227
2019
Q2
$177K Buy
+1,500
New +$151K 0.02% 194
2019
Q1
Sell
-1,500
Closed -$95K 233
2018
Q4
$95K Buy
+1,500
New +$103K 0.01% 222

Other funds holding EXAS

Phocas Financial Corp's EXAS Position: Q1 2023 in Review

Phocas Financial Corp sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 1,500 shares — an estimated $74.3K sold.

Phocas Financial Corp first reported a position in EXAS in Q4 2018 and held it in 3 quarters. The position peaked at $177K in Q2 2019. 583 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Phocas Financial Corp reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 1,500 Exact Sciences shares in Q1 2023, an estimated $74.3K.
  • Phocas Financial Corp first reported a position in Exact Sciences in Q4 2018 and held it in 3 quarters.
  • Phocas Financial Corp's Exact Sciences position peaked at $177K in Q2 2019.
  • 583 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Phocas Financial Corp's 13F filing for Q1 2023, filed 13 Apr 2023.